166 related articles for article (PubMed ID: 36017804)
1. Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis.
Bajaj JS; Reddy KR; Tandon P; Garcia-Tsao G; Kamath PS; O'Leary JG; Wong F; Lai J; Vargas H; Thuluvath PJ; Subramanian RM; Pena-Rodriguez M; Sikaroodi M; Thacker LR; Gillevet PM
Liver Transpl; 2022 Dec; 28(12):1831-1840. PubMed ID: 36017804
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.
Bajaj JS; OʼLeary JG; Tandon P; Wong F; Garcia-Tsao G; Kamath PS; Biggins SW; Lai JC; Vargas HE; Maliakkal B; Fallon MB; Thuluvath PJ; Subramanian RM; Thacker LR; Reddy KR
Am J Gastroenterol; 2019 Jul; 114(7):1091-1100. PubMed ID: 31180922
[TBL] [Abstract][Full Text] [Related]
3. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis.
Bajaj JS; Kamath PS; Reddy KR; Asrani SK; Keaveny AP; Tandon P; Duarte-Rojo A; Kappus M; Verna E; Biggins SW; Vargas HE; Albhaisi S; Shaw J; Dahiya M; Filipek N; Fallahzadeh MA; Wegermann K; Cabello R; Bera C; Thuluvath P; Bush B; Thacker LR; Wong F
Am J Gastroenterol; 2024 Apr; 119(4):712-718. PubMed ID: 37938163
[TBL] [Abstract][Full Text] [Related]
5. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
[TBL] [Abstract][Full Text] [Related]
6. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.
Bajaj JS; O'Leary JG; Reddy KR; Wong F; Olson JC; Subramanian RM; Brown G; Noble NA; Thacker LR; Kamath PS;
Hepatology; 2012 Dec; 56(6):2328-35. PubMed ID: 22806618
[TBL] [Abstract][Full Text] [Related]
7. Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis.
Bajaj JS; Garcia-Tsao G; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Subramanian RM; Thuluvath P; Fagan A; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Wong F
Hepatology; 2021 Nov; 74(5):2699-2713. PubMed ID: 34002868
[TBL] [Abstract][Full Text] [Related]
8. Posttraumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis.
Bajaj JS; Sikaroodi M; Fagan A; Heuman D; Gilles H; Gavis EA; Fuchs M; Gonzalez-Maeso J; Nizam S; Gillevet PM; Wade JB
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G661-G669. PubMed ID: 31460790
[TBL] [Abstract][Full Text] [Related]
9. Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort.
Bajaj JS; Tandon P; O'Leary JG; Reddy KR; Garcia-Tsao G; Thuluvath P; Lai JC; Subramanian RM; Vargas HE; Wong F; Fagan A; McGeorge S; Thacker LR; Kamath PS
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):1031-1040.e3. PubMed ID: 35436625
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis.
Álvares-da-Silva MR; Oliveira CP; Fagan A; Longo L; Thoen RU; Yoshimura Zitelli PM; Tanaka Ferreira RM; Mcgeorge S; Shamsaddini A; Farias AQ; Sikaroodi M; Gillevet PM; Bajaj JS
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):930-940. PubMed ID: 33813071
[TBL] [Abstract][Full Text] [Related]
11. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
[TBL] [Abstract][Full Text] [Related]
12. Impact of bacterial infections and spontaneous bacterial peritonitis prophylaxis on phage-bacterial dynamics in cirrhosis.
Bajaj JS; Rodriguez MP; Fagan A; McGeorge S; Sterling RK; Lee H; Luketic V; Fuchs M; Davis BC; Sikaroodi M; Gillevet PM
Hepatology; 2022 Dec; 76(6):1723-1734. PubMed ID: 35561076
[TBL] [Abstract][Full Text] [Related]
13. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
14. Reduction in Nosocomial Infections in Patients With Cirrhosis During the COVID-19 Era Compared with Pre-COVID-19: Impact of Masking and Restricting Visitation.
Park D; Houston K; Duong NK; Dharia N; Kamath PS; Bajaj JS
Am J Gastroenterol; 2022 Nov; 117(11):1874-1876. PubMed ID: 35862828
[TBL] [Abstract][Full Text] [Related]
15. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
[TBL] [Abstract][Full Text] [Related]
16. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis.
Piotrowski D; Sączewska-Piotrowska A; Jaroszewicz J; Boroń-Kaczmarska A
Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32155772
[No Abstract] [Full Text] [Related]
18. Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis.
Albhaisi S; Shamsaddini A; Fagan A; McGeorge S; Sikaroodi M; Gavis E; Patel S; Davis BC; Acharya C; Sterling RK; Matherly S; Fuchs M; Gillevet PM; Bajaj JS
Liver Transpl; 2021 May; 27(5):629-640. PubMed ID: 33492761
[TBL] [Abstract][Full Text] [Related]
19. Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites.
Schultalbers M; Tergast TL; Simon N; Kabbani AR; Kimmann M; Zu Siederdissen CH; Gerbel S; Manns MP; Cornberg M; Maasoumy B
United European Gastroenterol J; 2020 Jun; 8(5):567-576. PubMed ID: 32213043
[TBL] [Abstract][Full Text] [Related]
20. Serum and urinary metabolomics and outcomes in cirrhosis.
Bajaj JS; Fan S; Thacker LR; Fagan A; Gavis E; White MB; Heuman DM; Fuchs M; Fiehn O
PLoS One; 2019; 14(9):e0223061. PubMed ID: 31560724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
